CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade IQVIA Holdings Inc. (Extended hours) - IQV CFD

171.17
1.74%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 00:00

Mon - Thu: 08:00 - 00:00

Fri: 08:00 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.34
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023485 %
Charges from full value of position ($-4.46)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023485%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001262 %
Charges from full value of position ($0.24)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001262%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 174.71
Open 174.87
1-Year Change -30.84%
Day's Range 171.62 - 177.24
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 31, 2025 175.05 -1.79 -1.01% 176.84 177.67 169.34
Mar 28, 2025 176.62 -3.52 -1.95% 180.14 180.14 175.84
Mar 27, 2025 176.89 -2.56 -1.43% 179.45 180.53 176.72
Mar 26, 2025 178.08 -3.87 -2.13% 181.95 181.95 177.95
Mar 25, 2025 180.73 -3.37 -1.83% 184.10 187.06 179.26
Mar 24, 2025 185.22 -2.73 -1.45% 187.95 188.11 184.18
Mar 21, 2025 185.59 2.89 1.58% 182.70 185.91 179.40
Mar 20, 2025 183.47 -4.48 -2.38% 187.95 187.95 181.80
Mar 19, 2025 183.28 -5.92 -3.13% 189.20 189.33 183.28
Mar 18, 2025 187.46 1.52 0.82% 185.94 188.51 179.95
Mar 17, 2025 184.18 -0.77 -0.42% 184.95 186.17 179.95
Mar 14, 2025 181.55 1.58 0.88% 179.97 187.62 178.03
Mar 13, 2025 178.18 -6.76 -3.66% 184.94 186.44 178.18
Mar 12, 2025 182.27 -2.17 -1.18% 184.44 186.35 181.77
Mar 11, 2025 182.73 -12.22 -6.27% 194.95 194.95 180.62
Mar 10, 2025 185.07 -5.88 -3.08% 190.95 192.84 185.07
Mar 7, 2025 190.63 8.67 4.76% 181.96 191.72 181.94
Mar 6, 2025 184.73 1.78 0.97% 182.95 187.60 181.94
Mar 5, 2025 185.17 5.27 2.93% 179.90 186.02 179.90
Mar 4, 2025 183.48 -2.46 -1.32% 185.94 186.25 179.23

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Iqvia Company profile

About Iqvia Holdings Inc

IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The Company’s segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions, which primarily serves biopharmaceutical clients, is engaged in research and development and provides clinical research and clinical trial services. Contract Sales & Medical Solutions provides contract sales to both biopharmaceutical clients and the broader healthcare market.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Iqvia Holdings Inc revenues increased 22% to $13.87B. Net income increased from $279M to $966M. Revenues reflect Research & Development Solutions segment increase of 31% to $7.56B, Technology & Analytics Solutions segment increase of 14% to $5.53B, Contract Sales & Medical Solutions segment increase of 6% to $784M.

Equity composition

Common Stock $0.01 Par, 05/13/, Shares auth. 150M., 129,606,179 issd. Insiders owns approx. 84.77%

Industry: Biotechnology & Medical Research (NEC)

2400 Ellis Road
DURHAM
NORTH CAROLINA 27703
US

People also watch

ETH/USD

1,923.14 Price
+5.470% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

XRP/USD

2.15 Price
+2.590% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01073

US100

19,383.10 Price
+0.640% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

85,325.15 Price
+3.410% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading